tiprankstipranks
Advertisement
Advertisement
Cocrystal Pharma gains IRB approval for norovirus trial
PremiumCompany AnnouncementsCocrystal Pharma gains IRB approval for norovirus trial
3M ago
Cocrystal Pharma receives IRB approval from Emory University for Phase 1b trial
Premium
The Fly
Cocrystal Pharma receives IRB approval from Emory University for Phase 1b trial
3M ago
Cocrystal Pharma to Present at Emerging Growth Conference
Premium
Company Announcements
Cocrystal Pharma to Present at Emerging Growth Conference
4M ago
Cocrystal Pharma Secures NIH Award for Antiviral Research
PremiumCompany AnnouncementsCocrystal Pharma Secures NIH Award for Antiviral Research
5M ago
Cocrystal Pharma receives NIH SBIR award to advance influenza inhibitor program
Premium
The Fly
Cocrystal Pharma receives NIH SBIR award to advance influenza inhibitor program
5M ago
Cocrystal Pharma files to sell 5.74M shares of common stock for holders
Premium
The Fly
Cocrystal Pharma files to sell 5.74M shares of common stock for holders
6M ago
Cocrystal Pharma showcases CDI-988, antiviral for norovirus infection
PremiumThe FlyCocrystal Pharma showcases CDI-988, antiviral for norovirus infection
7M ago
Cocrystal Pharma receives IND clearance for challenge study of CDI-988
Premium
The Fly
Cocrystal Pharma receives IND clearance for challenge study of CDI-988
7M ago
Cocrystal Pharma reports Q2 EPS (20c), consensus (30c)
Premium
The Fly
Cocrystal Pharma reports Q2 EPS (20c), consensus (30c)
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100